biopharma mergers and acquisitions

Q3 2019 M&A highlights

We’ve recently wrapped up analysis of Q3 2019 M&A activity around the world.  Here are a few highlights: Q3 2019 new M&A volume and total deal value increased by 4% and 10%, respectively Total disclosed biopharma mergers and acquisitions (M&A) volume increased slightly in the third quarter of 2019, up 4% from 140 new M&As […]

Cortellis report: M&A value decreases by 7% to $105.3bn in Q2 2019

In early 2019, we released an in-depth analysis of 2018 deals activity. Here, we examine more recent activities and discuss mergers and acquisitions in the second quarter of 2019.   More deals, but lower total value Total disclosed biopharma mergers and acquisitions (M&A) value dropped slightly in the second quarter of 2019, down 7% from […]